• 1
    Reed E. Cisplatin, carboplatin, and oxaliplatin. In: ChabnerBA, LongoDL, eds. Cancer Chemotherapy and Biotherapy: Principles and Practice, 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006:332343.
  • 2
    Page RL, McEntee MC, George SL, et al. Pharmacokinetic and phase I evaluation of carboplatin in dogs. J Vet Intern Med 1993;7:235240.
  • 3
    Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med 1996;10:7681.
  • 4
    Chun R, Knapp DW, Widmer WR, et al. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1997;11:279283.
  • 5
    Rassnick KM, Ruslander DM, Cotter SM, et al. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000). J Am Vet Med Assoc 2001;218:14441448.
  • 6
    Chun R, Garrett LD, Vail DM. Cancer chemotherapy. In: WithrowSJ, VailDM, eds. Small Animal Clinical Oncology, 4th ed. St Louis, MO: Saunders Elsevier; 2007:163192.
  • 7
    Knapp DW, Richardson RC, DeNicola DB, et al. Cisplatin toxicity in cats. J Vet Intern Med 1987;1:2935.
  • 8
    Dhaliwal RS, Johnson TO, Kitchell BE. Primary extraskeletal hepatic osteosarcoma in a cat. J Am Vet Med Assoc 2003;222:340342, 316.
  • 9
    Sparkes A, Murphy S, McConnell F, et al. Palliative intracavitary carboplatin therapy in a cat with suspected pleural mesothelioma. J Feline Med Surg 2005;7:313316.
  • 10
    Spugnini EP, Ruslander D, Bartolazzi A. Extraskeletal osteosarcoma in a cat. J Am Vet Med Assoc 2001;219:6062, 49.
  • 11
    Hahn KA, McEntee MF, Daniel GB, et al. Hematologic and systemic toxicoses associated with carboplatin administration in cats. Am J Vet Res 1997;58:677679.
  • 12
    Bailey DB, Rassnick KM, Erb HN, et al. Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors. Am J Vet Res 2004;65:15021507.
  • 13
    Theon AP, VanVechten MK, Madewell BR. Intratumoral administration of carboplatin for treatment of squamous cell carcinomas of the nasal plane in cats. Am J Vet Res 1996;57:205210.
  • 14
    Veterinary Co-Operative Oncology Group. Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comparative Oncol 2004;2:195213.